Therefore, it is provocative to test the use of GHRAs as a case-specific maintenance protocol against tumor relapse or as a preventive regimen in high-risk cases of age-associated tumor development promoted by local GH action in tissues [13] (not tested here). Here, GH1 is linked to neoplasm.